Oncology Resource Group

Oncology Competitive Intelligence Leaders

AACR 2026: Beyond the Abstracts: Webinar

May 12, 2026

Regina Cheung, Ph.D., Amanda Koch, Ph.D. and Carla Cabrera Johnson, Ph.D.

Access Briefing

    Watch Now






    Executive Summary: ONCrg's PhD analysts review the most significant early-stage oncology developments from AACR 2026 and preview key data expected at ASCO, covering cell therapies, antibody-drug conjugates (ADCs), immuno-oncology, and the DNA damage response (DDR) space.

    • AACR 2026
    • Cell Therapies
    • Antibody-Drug Conjugates

      Sample Request

      How Did You Hear About Us

        Request Sample


        Please fill out the form below.

        We provide our samples for no charge to potential pharmaceutical clients, practicing physicians, and academic researchers.

        *Limited to one per year, other restrictions may apply.

        Select the Conferences of Interest:

          Request Planner


          Please fill out the form below.

          We provide our planners for no charge to potential pharmaceutical clients, practicing physicians, and academic researchers.

          *Limited to one per year, other restrictions may apply.

          Select the Conferences of Interest: